FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:586 August 24, 2000 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: A 44-year-old man with moderately severe asthma was first seen in the infectious-disease clinic in November 1999 because of a recent diagnosis of pulmonary aspergillosis. The patient had noted an increase in his asthma symptoms during the summer of 1999. A chest x-ray film obtained at that time had revealed bilateral cavitary lesions. An open-lung biopsy in September 1999 had revealed chronic necrotizing aspergillosis.

The patient had no known history of immunosuppression. His medications included fluticasone (delivered in two puffs of 220 µg four times a day [total daily dose, 1760 µg]) and zafirlukast (20 mg per . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Du, H., Huang, W. (2009). Chronic Necrotizing Pulmonary Aspergillosis or Invasive Pulmonary Aspergillosis. Chest 136: 1189-1190 [Full Text]  
• Bulpa, P., Dive, A., Sibille, Y. (2007). Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 30: 782-800 [Abstract] [Full Text]  
• Bratton, R. L., Brazis, P. W., Hellinger, W. C., Wharen, R. E. Jr, Broderick, D. F. (2002). Aspergillosis Related to Long-Term Nasal Corticosteroid Use. Mayo Clin Proc. 77: 1353-1357 [Abstract]